• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, September 7, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Long-COVID a greater burden for migrant groups than the native population

Bioengineer by Bioengineer
April 7, 2023
in Health
Reading Time: 3 mins read
0
Long-Covid per Group
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

All prominent migrant groups in the Netherlands are suffering more from long-covid than the native Dutch population, research from Amsterdam UMC has found. The study, published today, in The Lancet Regional Health – Europe, shows that in some groups the rates of long-covid are up to 50% larger than in the Dutch population. Resulting in many migrant groups “suffering in silence,” in the words of senior author Professor Charles Agyemang. 

Long-Covid per Group

Credit: Amsterdam UMC

All prominent migrant groups in the Netherlands are suffering more from long-covid than the native Dutch population, research from Amsterdam UMC has found. The study, published today, in The Lancet Regional Health – Europe, shows that in some groups the rates of long-covid are up to 50% larger than in the Dutch population. Resulting in many migrant groups “suffering in silence,” in the words of senior author Professor Charles Agyemang. 

COVID-19 has had a devastating impact on vulnerable communities, particularly people from ethnic minorities and migrant backgrounds. Research from Amsterdam UMC already found that these populations have been severely impacted by the virus and were several times more likely to be infected with and die from COVID-19 compared to majority populations in high-income countries. Various factors, including poor social and economic circumstances, communication barriers, and health literacy contribute to this disparity. 

To investigate the long-term impact of COVID-19 on patients from diverse backgrounds, including Dutch origin patients, African Surinamese, South Asian Surinamese, Moroccan, and Turkish origin patients, Amsterdam UMC collaborated with the University of Copenhagen and Stockholm University to conduct a study. 

Their findings revealed that about 26% of the patients who were hospitalized with COVID developed long-COVID. All the migrant groups had a higher risk of developing long-COVID than Dutch patients. Among the Turkish population, this risk is 50% higher than in the native Dutch population. Females, as well as patients who stayed longer in the hospital, were admitted to the intensive care unit, and received oxygen, were also more likely to develop long-COVID than those who did not. 

The study also found that the experience of long-COVID symptoms differed between the groups. For example, experience of dizziness, and muscle and joint pain were highest among Turkish origin patients compared to other patient groups. On the other hand, experience of a racing heart, and trouble sleeping were highest among patients from Moroccan origin. Finally, the study found that about 14% of long-COVID symptoms were still persistent at one-year post-discharge, particularly among South Asian Surinamese origin patients. 

According to the senior author of the paper, Professor Charles Agyemang, Professor of Global Migration, Ethnicity & Health at the Amsterdam UMC, the findings were not surprising as “the social determinants of health that shaped the disproportionately high rate of COVID-19 infection and deaths in ethnic minority and migrants are still at play.” 

“Many vulnerable populations in the community are suffering from long-COVID in silence due to a lack of awareness of the condition in these communities. Promoting awareness about long-COVID and facilitating easy access to healthcare and services in ethnic minorities and migrant communities and other vulnerable populations is crucial to addressing these health inequalities,” adds Agyemang 

The lead author, Dr Felix Chilunga, an Assistant Professor at the Amsterdam University Medical Centre, added that “patients with long-COVID are likely to face functional limitations in their daily lives, such as being unable to work or do activities of daily living. The extent of these limitations is still unknown. Therefore, checking the extent to which long-COVID affects daily activities can ensure a targeted approach to the symptoms that contribute to the greatest limitations.” 



Journal

The Lancet Regional Health – Europe

Method of Research

Data/statistical analysis

Subject of Research

People

Article Title

Differences in incidence, nature of symptoms, and duration of long COVID among hospitalised migrant and non-migrant patients in the Netherlands: a retrospective cohort study

Article Publication Date

7-Apr-2023

COI Statement

B.A. and M.v.V. report Patient Led Research Collaboration (PLRC) grant paid to the host institution. W.J.W. reports consultancy fees from Pfizer, GSK, and AstraZeneca paid to the host institution, as well as being a member of GSK data and safety monitoring board (fees paid to host institution). All other authors declare that they have no competing interests.

Share12Tweet8Share2ShareShareShare2

Related Posts

Tackling Ageism: Nurse Education Intervention Proven Effective

September 7, 2025

Childhood Trauma, HIV, and Women’s Mental Health Insights

September 7, 2025

9-Fluorenone Sulfonamides: Dual Inhibitors of SARS-CoV-2 Proteases

September 7, 2025

Shikonin Blocks EMT in Glioblastoma via p53 Activation

September 7, 2025

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    150 shares
    Share 60 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • First Confirmed Human Mpox Clade Ib Case China

    55 shares
    Share 22 Tweet 14
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    47 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Zidesamtinib Demonstrates Lasting Efficacy in ROS1 TKI-Pretreated NSCLC, Including Cases with CNS Involvement and ROS1 G2032R Mutations

Crizotinib Does Not Enhance Disease-Free Survival in Resected Early-Stage ALK-Positive NSCLC

FLAURA2 Trial Demonstrates Enhanced Overall Survival with Osimertinib and Chemotherapy in EGFR-Mutated Advanced NSCLC

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.